CURIS, INC. Operating Cash Flow
CURIS, INC. (CRIS) reported Operating Cash Flow of -$18.65 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-14
- CURIS, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$9.65M.
- CURIS, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$9.00M.
- CURIS, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$6.37M.
- CURIS, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$5.57M.
- CURIS, INC. net cash provided by (used in) operating activities for fiscal 2025 was -$27.20M.
- CURIS, INC. net cash provided by (used in) operating activities for fiscal 2024 was -$39.56M.
- CURIS, INC. net cash provided by (used in) operating activities for fiscal 2023 was -$38.43M.
- CURIS, INC. net cash provided by (used in) operating activities for fiscal 2022 was -$54.34M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$9.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$18.65M 10-Q · filed 2026-08-14 | -$25.02M derived: sum of 3 quarters · filed 2026-08-14 | -$30.59M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2026-03-31 | -$9.00M 10-Q · filed 2026-05-13 | -$15.37M derived: sum of 2 quarters · filed 2026-05-13 | -$20.94M derived: sum of 3 quarters · filed 2026-05-13 | -$28.95M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-12-31 | -$6.37M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | -$11.94M derived: sum of 2 quarters · filed 2026-03-24 | -$19.95M derived: sum of 3 quarters · filed 2026-08-14 | -$27.20M 10-K · filed 2026-03-24 | |||
| 2025-09-30 | -$5.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$13.58M derived: sum of 2 quarters · filed 2026-08-14 | -$20.83M 10-Q · filed 2025-11-06 | -$30.09M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-06-30 | -$8.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$15.26M 10-Q · filed 2026-08-14 | -$24.52M derived: sum of 3 quarters · filed 2026-08-14 | -$30.46M derived: sum of 4 quarters · filed 2026-08-14 | |||
| 2025-03-31 | -$7.25M 10-Q · filed 2026-05-13 | -$16.51M derived: sum of 2 quarters · filed 2026-05-13 | -$22.45M derived: sum of 3 quarters · filed 2026-05-13 | -$33.58M derived: sum of 4 quarters · filed 2026-05-13 | |||
| 2024-12-31 | -$9.26M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | -$15.20M derived: sum of 2 quarters · filed 2026-03-24 | -$26.33M derived: sum of 3 quarters · filed 2026-03-24 | -$39.56M 10-K · filed 2026-03-24 | |||
| 2024-09-30 | -$5.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$17.07M derived: sum of 2 quarters · filed 2025-11-06 | -$30.30M 10-Q · filed 2025-11-06 | -$40.49M derived: sum of 4 quarters · filed 2025-11-06 | |||
| 2024-06-30 | -$11.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | -$24.37M 10-Q · filed 2025-08-05 | -$34.55M derived: sum of 3 quarters · filed 2025-08-05 | -$42.73M derived: sum of 4 quarters · filed 2025-08-05 | |||
| 2024-03-31 | -$13.23M 10-Q · filed 2025-05-06 | -$23.42M derived: sum of 2 quarters · filed 2025-05-06 | -$31.60M derived: sum of 3 quarters · filed 2025-05-06 | -$39.47M derived: sum of 4 quarters · filed 2025-05-06 | |||
| 2023-12-31 | -$10.19M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$18.37M derived: sum of 2 quarters · filed 2025-03-31 | -$26.23M derived: sum of 3 quarters · filed 2025-03-31 | -$38.43M 10-K · filed 2025-03-31 | |||
| 2023-09-30 | -$8.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$16.05M derived: sum of 2 quarters · filed 2024-11-14 | -$28.25M 10-Q · filed 2024-11-14 | -$40.52M derived: sum of 4 quarters · filed 2024-11-14 | |||
| 2023-06-30 | -$7.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | -$20.07M 10-Q · filed 2024-08-01 | -$32.34M derived: sum of 3 quarters · filed 2024-08-01 | -$45.46M derived: sum of 4 quarters · filed 2024-08-01 | |||
| 2023-03-31 | -$12.20M 10-Q · filed 2024-05-07 | -$24.47M derived: sum of 2 quarters · filed 2024-05-07 | -$37.59M derived: sum of 3 quarters · filed 2024-05-07 | -$49.72M derived: sum of 4 quarters · filed 2024-05-07 | |||
| 2022-12-31 | -$12.27M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-08 | -$25.39M derived: sum of 2 quarters · filed 2024-02-08 | -$37.52M derived: sum of 3 quarters · filed 2024-02-08 | -$54.34M 10-K · filed 2024-02-08 | |||
| 2022-09-30 | -$13.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$25.25M derived: sum of 2 quarters · filed 2023-11-02 | -$42.07M 10-Q · filed 2023-11-02 | -$50.24M derived: sum of 4 quarters · filed 2023-11-02 | |||
| 2022-06-30 | -$12.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$28.95M 10-Q · filed 2023-08-03 | -$37.12M derived: sum of 3 quarters · filed 2023-08-03 | -$46.73M derived: sum of 4 quarters · filed 2023-08-03 | |||
| 2022-03-31 | -$16.82M 10-Q · filed 2023-05-04 | -$24.99M derived: sum of 2 quarters · filed 2023-05-04 | -$34.60M derived: sum of 3 quarters · filed 2023-05-04 | -$41.26M derived: sum of 4 quarters · filed 2023-05-04 | |||
| 2021-12-31 | -$8.17M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13 | -$17.78M derived: sum of 2 quarters · filed 2023-03-13 | -$24.44M derived: sum of 3 quarters · filed 2023-03-13 | -$37.62M 10-K · filed 2023-03-13 | |||
| 2021-09-30 | -$9.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$16.27M derived: sum of 2 quarters · filed 2022-11-09 | -$29.45M 10-Q · filed 2022-11-09 | -$35.16M derived: sum of 4 quarters · filed 2022-11-09 | |||
| 2021-06-30 | -$6.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$19.84M 10-Q · filed 2022-08-04 | -$25.55M derived: sum of 3 quarters · filed 2022-08-04 | -$31.43M derived: sum of 4 quarters · filed 2022-08-04 | |||
| 2021-03-31 | -$13.18M 10-Q · filed 2022-05-05 | -$18.89M derived: sum of 2 quarters · filed 2022-05-05 | -$24.77M derived: sum of 3 quarters · filed 2022-05-05 | -$29.90M derived: sum of 4 quarters · filed 2022-05-05 | |||
| 2020-12-31 | -$5.71M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$11.59M derived: sum of 2 quarters · filed 2022-02-24 | -$16.72M derived: sum of 3 quarters · filed 2022-02-24 | -$25.74M 10-K · filed 2022-02-24 | |||
| 2020-09-30 | -$5.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$11.01M derived: sum of 2 quarters · filed 2021-11-09 | -$20.02M 10-Q · filed 2021-11-09 | -$25.62M derived: sum of 4 quarters · filed 2022-02-24 | |||
| 2020-06-30 | -$5.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | -$14.15M 10-Q · filed 2021-08-03 | -$19.75M derived: sum of 3 quarters · filed 2022-02-24 | -$26.45M derived: sum of 4 quarters · filed 2022-02-24 | |||
| 2020-03-31 | -$9.02M 10-Q · filed 2021-05-12 | -$14.62M derived: sum of 2 quarters · filed 2022-02-24 | -$21.32M derived: sum of 3 quarters · filed 2022-02-24 | -$27.99M derived: sum of 4 quarters · filed 2022-02-24 | |||
| 2019-12-31 | -$5.60M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$12.30M derived: sum of 2 quarters · filed 2022-02-24 | -$18.97M derived: sum of 3 quarters · filed 2022-02-24 | -$26.20M 10-K · filed 2022-02-24 | |||
| 2019-09-30 | -$6.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | -$13.37M derived: sum of 2 quarters · filed 2020-11-10 | -$20.61M 10-Q · filed 2020-11-10 | -$25.55M derived: sum of 4 quarters · filed 2020-11-10 | |||
| 2019-06-30 | -$6.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | -$13.90M 10-Q · filed 2020-08-04 | -$12.72M 10-Q · filed 2019-08-09 | -$18.84M derived: sum of 3 quarters · filed 2020-08-04 | -$27.07M derived: sum of 4 quarters · filed 2020-08-04 | ||
| 2019-03-31 | -$7.23M 10-Q · filed 2020-05-12 | -$10.60M 10-Q · filed 2019-05-14 | -$12.17M derived: sum of 2 quarters · filed 2020-05-12 | -$20.40M derived: sum of 3 quarters · filed 2020-05-12 | -$27.33M derived: sum of 4 quarters · filed 2020-05-12 | ||
| 2018-12-31 | -$4.94M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-19 | -$13.16M derived: sum of 2 quarters · filed 2020-03-19 | -$20.10M derived: sum of 3 quarters · filed 2020-03-19 | -$30.07M 10-K · filed 2020-03-19 | |||
| 2018-09-30 | -$8.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | -$15.16M derived: sum of 2 quarters · filed 2019-11-05 | -$25.13M 10-Q · filed 2019-11-05 | -$32.63M derived: sum of 4 quarters · filed 2019-11-05 | |||
| 2018-06-30 | -$6.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | -$16.90M 10-Q · filed 2019-08-09 | -$24.41M derived: sum of 3 quarters · filed 2019-08-09 | -$40.89M derived: sum of 4 quarters · filed 2019-08-09 | |||
| 2018-03-31 | -$9.96M 10-Q · filed 2019-05-14 | -$17.47M derived: sum of 2 quarters · filed 2019-05-14 | -$33.95M derived: sum of 3 quarters · filed 2019-05-14 | ||||
| 2017-12-31 | -$7.50M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26 | -$23.99M derived: sum of 2 quarters · filed 2019-03-26 | -$48.35M 10-K · filed 2019-03-26 | ||||
| 2017-09-30 | -$16.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | -$40.85M 10-Q · filed 2018-11-01 | |||||
| 2017-06-30 | -$24.37M 10-Q · filed 2018-08-02 | ||||||
| 2016-12-31 | -$35.81M 10-K · filed 2018-03-08 | ||||||
| 2015-12-31 | -$29.89M 10-K · filed 2018-03-08 | ||||||
| 2014-12-31 | -$16.81M 10-K · filed 2017-03-09 | ||||||
| 2013-12-31 | -$5.51M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13 | -$5.24M derived: sum of 2 quarters · filed 2014-03-13 | -$5.21M derived: sum of 3 quarters · filed 2014-03-13 | -$9.54M 10-K · filed 2014-03-13 | |||
| 2013-09-30 | $277.40K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $301.23K derived: sum of 2 quarters · filed 2013-11-12 | -$4.03M 10-Q · filed 2013-11-12 | -$17.37M derived: sum of 4 quarters · filed 2014-03-13 | |||
| 2013-06-30 | $23.84K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | -$4.30M 10-Q · filed 2013-08-08 | -$17.64M derived: sum of 3 quarters · filed 2014-03-13 | -$21.82M derived: sum of 4 quarters · filed 2014-03-13 | |||
| 2013-03-31 | -$4.33M 10-Q · filed 2013-05-09 | -$17.67M derived: sum of 2 quarters · filed 2014-03-13 | -$21.85M derived: sum of 3 quarters · filed 2014-03-13 | -$23.46M derived: sum of 4 quarters · filed 2014-03-13 | |||
| 2012-12-31 | -$13.34M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13 | -$17.52M derived: sum of 2 quarters · filed 2014-03-13 | -$19.13M derived: sum of 3 quarters · filed 2014-03-13 | -$15.19M 10-K · filed 2014-03-13 | |||
| 2012-09-30 | -$4.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | -$5.79M derived: sum of 2 quarters · filed 2013-11-12 | -$1.85M 10-Q · filed 2013-11-12 | -$1.48M 10-Q · filed 2012-11-06 | $6.83M derived: sum of 4 quarters · filed 2014-03-13 | ||
| 2012-06-30 | -$1.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $2.33M 10-Q · filed 2013-08-08 | $2.70M 10-Q · filed 2012-08-09 | $11.01M derived: sum of 3 quarters · filed 2014-03-13 | $6.59M derived: sum of 4 quarters · filed 2014-03-13 | ||
| 2012-03-31 | $3.94M 10-Q · filed 2013-05-09 | $4.31M 10-Q · filed 2012-05-10 | $12.63M derived: sum of 2 quarters · filed 2014-03-13 | $8.20M derived: sum of 3 quarters · filed 2014-03-13 | $4.00M derived: sum of 4 quarters · filed 2014-03-13 | ||
| 2011-12-31 | $8.69M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13 | $4.26M derived: sum of 2 quarters · filed 2014-03-13 | $65.08K derived: sum of 3 quarters · filed 2014-03-13 | -$4.56M 10-K · filed 2014-03-13 | |||
| 2011-09-30 | -$4.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | -$8.62M derived: sum of 2 quarters · filed 2012-11-06 | -$13.25M 10-Q · filed 2012-11-06 | -$16.97M derived: sum of 4 quarters · filed 2013-03-13 | |||
| 2011-06-30 | -$4.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | -$8.83M 10-Q · filed 2012-08-09 | -$12.55M derived: sum of 3 quarters · filed 2013-03-13 | -$13.38M derived: sum of 4 quarters · filed 2013-03-13 | |||
| 2011-03-31 | -$4.63M 10-Q · filed 2012-05-10 | -$8.35M derived: sum of 2 quarters · filed 2013-03-13 | -$9.18M derived: sum of 3 quarters · filed 2013-03-13 | ||||
| 2010-12-31 | -$3.72M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-13 | -$4.55M derived: sum of 2 quarters · filed 2013-03-13 | -$1.63M 10-K · filed 2013-03-13 | ||||
| 2010-09-30 | -$831.02K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-31 | $2.09M 10-Q · filed 2011-10-31 | |||||
| 2010-06-30 | $2.92M 10-Q · filed 2011-08-04 | ||||||
| 2009-12-31 | -$7.59M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |